These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1220 related items for PubMed ID: 24836057

  • 1. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
    Klein EA, Cooperberg MR, Magi-Galluzzi C, Simko JP, Falzarano SM, Maddala T, Chan JM, Li J, Cowan JE, Tsiatis AC, Cherbavaz DB, Pelham RJ, Tenggara-Hunter I, Baehner FL, Knezevic D, Febbo PG, Shak S, Kattan MW, Lee M, Carroll PR.
    Eur Urol; 2014 Sep; 66(3):550-60. PubMed ID: 24836057
    [Abstract] [Full Text] [Related]

  • 2. A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer.
    Cullen J, Rosner IL, Brand TC, Zhang N, Tsiatis AC, Moncur J, Ali A, Chen Y, Knezevic D, Maddala T, Lawrence HJ, Febbo PG, Srivastava S, Sesterhenn IA, McLeod DG.
    Eur Urol; 2015 Jul; 68(1):123-31. PubMed ID: 25465337
    [Abstract] [Full Text] [Related]

  • 3. A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease.
    Van Den Eeden SK, Lu R, Zhang N, Quesenberry CP, Shan J, Han JS, Tsiatis AC, Leimpeter AD, Lawrence HJ, Febbo PG, Presti JC.
    Eur Urol; 2018 Jan; 73(1):129-138. PubMed ID: 28988753
    [Abstract] [Full Text] [Related]

  • 4. A 17-Gene Genomic Prostate Score as a Predictor of Adverse Pathology in Men on Active Surveillance.
    Kornberg Z, Cooperberg MR, Cowan JE, Chan JM, Shinohara K, Simko JP, Tenggara I, Carroll PR.
    J Urol; 2019 Oct; 202(4):702-709. PubMed ID: 31026214
    [Abstract] [Full Text] [Related]

  • 5. A 17-Gene Panel Genomic Prostate Score Has Similar Predictive Accuracy for Adverse Pathology at Radical Prostatectomy in African American and European American Men.
    Murphy AB, Carbunaru S, Nettey OS, Gornbein C, Dixon MA, Macias V, Sharifi R, Kittles RA, Yang X, Kajdacsy-Balla A, Gann P.
    Urology; 2020 Aug; 142():166-173. PubMed ID: 32277993
    [Abstract] [Full Text] [Related]

  • 6. Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort.
    Cooperberg MR, Davicioni E, Crisan A, Jenkins RB, Ghadessi M, Karnes RJ.
    Eur Urol; 2015 Feb; 67(2):326-33. PubMed ID: 24998118
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Multiple Tissue Biomarkers Independently and Additively Predict Prostate Cancer Pathology Outcomes.
    Cooperberg MR, Cowan JE, Lindquist KJ, Kobayashi Y, Simko JP, Bengtsson H, Singh K, Ngo V, Avila A, Newcomb LF, Tretriakova M, Lin DW, Stone S, Carroll PR, Paris PL.
    Eur Urol; 2021 Jan; 79(1):141-149. PubMed ID: 33148472
    [Abstract] [Full Text] [Related]

  • 10. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM, Casey RG, Hong MK, Pedersen J, Connolly S, Peters J, Harewood L, Gleave ME, Costello AJ, Hovens CM, Goldenberg SL.
    BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.
    Roobol MJ, Verbeek JFM, van der Kwast T, Kümmerlin IP, Kweldam CF, van Leenders GJLH.
    Eur Urol; 2017 Jul; 72(1):45-51. PubMed ID: 28162815
    [Abstract] [Full Text] [Related]

  • 14. A 17-gene Panel for Prediction of Adverse Prostate Cancer Pathologic Features: Prospective Clinical Validation and Utility.
    Eggener S, Karsh LI, Richardson T, Shindel AW, Lu R, Rosenberg S, Goldfischer E, Korman H, Bennett J, Newmark J, Denes BS.
    Urology; 2019 Apr; 126():76-82. PubMed ID: 30611659
    [Abstract] [Full Text] [Related]

  • 15. Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer.
    Preisser F, Marchioni M, Nazzani S, Bandini M, Tian Z, Saad F, Pompe RS, Briganti A, Budäus L, Montorsi F, Huland H, Graefen M, Tilki D, Karakiewicz PI.
    Eur Urol Oncol; 2018 Jun; 1(2):160-168. PubMed ID: 31100241
    [Abstract] [Full Text] [Related]

  • 16. Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer.
    Masic S, Cowan JE, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR.
    Eur Urol Oncol; 2018 Oct; 1(5):386-394. PubMed ID: 31158077
    [Abstract] [Full Text] [Related]

  • 17. The 17-Gene Genomic Prostate Score Assay Predicts Outcome After Radical Prostatectomy Independent of PTEN Status.
    Magi-Galluzzi C, Isharwal S, Falzarano SM, Tsiatis A, Dee A, Maddala T, Knezevic D, Febbo PG, Lawrence J, Klein EA.
    Urology; 2018 Nov; 121():132-138. PubMed ID: 30142405
    [Abstract] [Full Text] [Related]

  • 18. The 4Kscore Predicts the Grade and Stage of Prostate Cancer in the Radical Prostatectomy Specimen: Results from a Multi-institutional Prospective Trial.
    Punnen S, Nahar B, Prakash NS, Sjoberg DD, Zappala SM, Parekh DJ.
    Eur Urol Focus; 2017 Feb; 3(1):94-99. PubMed ID: 28720374
    [Abstract] [Full Text] [Related]

  • 19. Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy.
    Pierorazio PM, Ross AE, Lin BM, Epstein JI, Han M, Walsh PC, Partin AW, Pavlovich CP, Schaeffer EM.
    BJU Int; 2012 Oct; 110(8):1122-8. PubMed ID: 22373045
    [Abstract] [Full Text] [Related]

  • 20. A reliable transcriptomic risk-score applicable to formalin-fixed paraffin-embedded biopsies improves outcome prediction in localized prostate cancer.
    Rade M, Kreuz M, Borkowetz A, Sommer U, Blumert C, Füssel S, Bertram C, Löffler D, Otto DJ, Wöller LA, Schimmelpfennig C, Köhl U, Gottschling AC, Hönscheid P, Baretton GB, Wirth M, Thomas C, Horn F, Reiche K.
    Mol Med; 2024 Feb 01; 30(1):19. PubMed ID: 38302875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.